Economic recovery times could blow out
Lockdown measures and the rise in COVID cases, particularly in the US, could stifle projected economic growth says Joshua Mahony, Senior Market Analyst at IG.
“Economic strife over the coming months will likely stifle the market rebound despite the impending vaccine, with today’s indecision highlighting that ongoing battle between optimism and the current reality. Meanwhile, retail is at risk as we head towards the festive period in lockdown.
“The surge in European equities appears to have petered out if early trade is anything to go by, with most major indices treading water after the open. In the UK, the lack of direction is shown by the huge daily fluctuations in value stocks.
“The emergence of an effective vaccine does provide reason for optimism, yet traders will have to weigh up whether the prospect of an eventual return to ‘normality’ can simply allow traders to overlook the major hurdles that remain in the meanwhile.
“The fear is that this incessant rise in US cases and deaths will ultimately force Joe Biden into a nationwide lockdown come January, with the fractured nature of the country meaning that any such restriction could be less effective than elsewhere.
“In Europe, we are yet to see the curve turn off the back of recent lockdown measures, with retail stocks at risk in the event that the virus forces even more prospective customers into the hands of Amazon.
“That fear for the high street has led to declines for the likes of Next and Primark-owned ABF, with the ability to release the lockdown shackles in time for the festive period likely to be key for many hard-hit retailers.”
Australia’s economic recovery is going to be faster and stronger than previously expected, according to Commonwealth Bank’s Head of Australian Economics Gareth Aird.
Mr Aird revised the profile for Gross Domestic Product (GDP) and said while he still expects GDP to contract by 3.3 per cent in 2020, he now expects to see a much “stronger recovery in 2021”, with a GDP growth prediction of 4.2 per cent in 2021 (up from the previous estimate of 2.5 per cent) and 3.8 per cent in 2022.
“When GDP and employment collapsed in Australia over Q2 20 comparisons were made with the Great Depression,” he said.
"We had not seen such a sharp deterioration in economic data since the 1930s. But the similarities between the Great Depression and the COVID-19 pandemic from an economic perspective only pertain to the Q2 20 activity data.
“There is not much about the Australian economy in 2020 that is analogous to the Great Depression, particularly the huge monetary and fiscal support injected into the economy.
“The Government’s fiscal support packages were designed to keep as much of the economic furniture intact so that when restrictions were eased activity could rebound swiftly. It is clear that the economic data at the national level has improved since the middle of the year. Indeed we expect a decent bounce in GDP over the second half of this year to show up in the Q3 20 and Q4 20 national accounts.”
Mr Aird said he was “optimistic” about the strength and duration of the economic recovery and said there was “plenty of evidence creeping into the data that signals strong outcomes next year are more likely than not”.
“Provided transmission of COVID-19 in Australia remains low, particularly community transmission, the strength of the economic recovery in 2021 will surprise many,” he said.
“We believe the metaphorical ‘bridge’ has been built very well and sets Australia up for a prosperous next two years.”
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.